INOVIO PHARMACEUTICALS, INC. Retained Earnings
INOVIO PHARMACEUTICALS, INC. (INO) had Retained Earnings of -$1.84 billion as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-12
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$1.84B.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$1.83B.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$1.82B.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$1.82B.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2026-06-30 | -$1.84B 10-Q · filed 2026-08-12 |
| 2026-03-31 | -$1.83B 10-Q · filed 2026-05-13 |
| 2025-12-31 | -$1.82B 10-Q · filed 2026-08-12 |
| 2025-09-30 | -$1.82B 10-Q · filed 2025-11-10 |
| 2025-06-30 | -$1.77B 10-Q · filed 2025-08-12 |
| 2025-03-31 | -$1.75B 10-Q · filed 2025-05-13 |
| 2024-12-31 | -$1.73B 10-K · filed 2026-03-12 |
| 2024-09-30 | -$1.71B 10-Q · filed 2024-11-14 |
| 2024-06-30 | -$1.69B 10-Q · filed 2024-08-08 |
| 2024-03-31 | -$1.65B 10-Q · filed 2024-05-13 |
| 2023-12-31 | -$1.62B 10-K · filed 2025-03-18 |
| 2023-09-30 | -$1.60B 10-Q · filed 2023-11-09 |
| 2023-06-30 | -$1.56B 10-Q · filed 2023-08-09 |
| 2023-03-31 | -$1.53B 10-Q · filed 2023-05-10 |
| 2022-12-31 | -$1.49B 10-K · filed 2024-03-06 |
| 2022-09-30 | -$1.43B 10-Q · filed 2022-11-08 |
| 2022-06-30 | -$1.40B 10-Q · filed 2022-08-09 |
| 2022-03-31 | -$1.29B 10-Q · filed 2022-05-10 |
| 2021-12-31 | -$1.21B 10-K · filed 2023-03-01 |
| 2021-09-30 | -$1.10B 10-Q · filed 2021-11-09 |
| 2021-06-30 | -$1.04B 10-Q · filed 2021-08-09 |
| 2021-03-31 | -$960.60M 10-Q · filed 2021-05-10 |
| 2020-12-31 | -$906.20M 10-K · filed 2022-03-01 |
| 2020-09-30 | -$881.86M 10-Q · filed 2020-11-09 |
| 2020-06-30 | -$901.03M 10-Q · filed 2020-08-10 |
| 2020-03-31 | -$772.33M 10-Q · filed 2020-05-11 |
| 2019-12-31 | -$739.79M 10-K · filed 2021-03-01 |
| 2019-09-30 | -$702.12M 10-Q · filed 2019-11-12 |
| 2019-06-30 | -$679.03M 10-Q · filed 2019-08-08 |
| 2019-03-31 | -$649.65M 10-Q · filed 2019-05-09 |
| 2018-12-31 | -$620.43M 10-K · filed 2020-03-12 |
| 2018-09-30 | -$587.13M 10-Q · filed 2018-11-08 |
| 2018-06-30 | -$562.11M 10-Q · filed 2018-08-07 |
| 2018-03-31 | -$555.48M 10-Q · filed 2018-05-09 |
| 2018-01-01 | -$523.12M 10-K · filed 2019-03-12 |
| 2017-12-31 | -$523.36M 10-K · filed 2019-03-12 |
| 2017-09-30 | -$501.85M 10-Q · filed 2017-11-08 |
| 2017-06-30 | -$467.72M 10-Q · filed 2017-08-08 |
| 2017-03-31 | -$458.24M 10-Q · filed 2017-05-10 |
| 2016-12-31 | -$434.84M 10-K · filed 2018-03-14 |
| 2016-09-30 | -$408.60M 10-Q · filed 2016-11-09 |
| 2016-06-30 | -$387.85M 10-Q · filed 2016-08-08 |
| 2016-03-31 | -$369.14M 10-Q · filed 2016-05-09 |
| 2015-12-31 | -$361.10M 10-K · filed 2017-03-15 |
| 2015-09-30 | -$343.15M 10-Q · filed 2015-11-09 |
| 2015-06-30 | -$348.74M 10-Q · filed 2015-08-10 |
| 2015-03-31 | -$342.49M 10-Q · filed 2015-05-11 |
| 2014-12-31 | -$331.91M 10-K · filed 2016-03-14 |
| 2014-09-30 | -$324.50M 10-Q · filed 2014-11-10 |
| 2014-06-30 | -$317.32M 10-Q · filed 2014-08-11 |
| 2014-03-31 | -$306.61M 10-Q · filed 2014-05-12 |
| 2013-12-31 | -$295.79M 10-K · filed 2015-03-16 |
| 2013-09-30 | -$280.33M 10-Q · filed 2013-11-12 |
| 2013-06-30 | -$249.46M 10-Q · filed 2013-08-09 |
| 2013-03-31 | -$238.60M 10-Q · filed 2013-05-10 |
| 2012-12-31 | -$229.76M 10-K · filed 2014-03-17 |
| 2012-09-30 | -$229.10M 10-Q · filed 2012-11-07 |
| 2012-06-30 | -$222.48M 10-Q · filed 2012-08-09 |
| 2012-03-31 | -$218.35M 10-Q · filed 2012-05-09 |
| 2011-12-31 | -$210.09M 10-K · filed 2013-03-18 |
| 2011-09-30 | -$204.61M 10-Q · filed 2011-11-07 |
| 2011-06-30 | -$200.07M 10-Q · filed 2011-08-05 |
| 2010-12-31 | -$194.84M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |